Live Breaking News & Updates on Reviva Pharmaceuticals Holdings
Stay updated with breaking news from Reviva pharmaceuticals holdings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Equities researchers at Zacks Small Cap lowered their FY2023 EPS estimates for Reviva Pharmaceuticals in a research note issued to investors on Monday, November 20th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will post earnings per share of ($1.43) for the year, […] ....
Reviva Pharmaceuticals (RVPH) Announces $30 Million Registered Direct Offering of Common Stock, Warrants streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q3 EPS by 8c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The pivotal phase III study of brilaroxazine from Reviva Pharmaceuticals Holdings Inc. for adults with schizophrenia hit its primary endpoint and two key secondary endpoints, following positive phase II data in 2021. The serotonin-dopamine signaling modulator, the company’s lead candidate, is a once-daily treatment. ....